Bortezomib Injection, Powder, Lyophilized, For Solution
Product Images NDC 72603-270

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Bortezomib (NDC 72603-270). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rxllc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cartonlabel (Cartonlabel)

Bortezomib For Injection 3.5 mg/vial lyophilized powder for solution packaging label. The label indicates it is for intravenous or subcutaneous use, single-dose vial, cytotoxic agent, and must be diluted. Manufactured by Dr. Reddy's Laboratories Limited in India for NorthStar Rx LLC. Storage instructions and reconstitution information for subcutaneous and intravenous injection are provided. The label includes barcodes and batch coding details.*

FDA Label Image

Figure1 (Figure1)

Kaplan-Meier survival curve comparing two patient groups over time in months. The y-axis shows the percentage of patients remaining, while the x-axis represents time in months. Two lines represent the groups Bortezomib-MP (red solid line) and MP (blue dashed line), with patient counts provided at various timepoints along the x-axis. A statistical p-value from a log-rank test is displayed in the lower left.*

FDA Label Image

Figure2 (Figure2)

A survival curve chart showing the percentage of patients over time in months, comparing Bortezomib-MP and MP treatments. The red dotted line represents Bortezomib-MP and the blue solid line represents MP. The chart includes a p-value from a log-rank test and displays numbers of patients at risk at various time points for each treatment group.*

FDA Label Image

Figure3 (Figure3)

A survival curve chart comparing the proportion of patients over time (days) treated with Bortezomib versus Dexamethasone. The graph shows a higher proportion of patients surviving longer with Bortezomib. Patient counts remaining at specific time points and a p-value from a log-rank test are also noted.*

FDA Label Image

Figure4 (Figure4)

A survival curve chart comparing the proportion of patients over time (in days) treated with Bortezomib versus Dexamethasone. The y-axis shows the proportion of patients, and the x-axis shows time in days. The chart includes patient counts at multiple time points and indicates a p-value less than 0.05 from a log-rank test, suggesting statistical analysis of the survival data.*

FDA Label Image

Figure5 (Figure5)

A Kaplan-Meier survival curve comparing two patient groups labeled VcR-CAP and R-CHOP over 60 months. The y-axis represents the percentage of patients, and the x-axis shows time in months. There is a log-rank test with a reported p-value of less than 0.001. Below the graph, a table displays the number of subjects at risk in each group at various time points.*

FDA Label Image

Figure6 (Figure6)

A survival curve chart showing the percentage of subjects alive over time in months from randomization, comparing two treatment groups: VcR-CAP (solid line) and R-CHOP (dashed line). The chart includes a hazard ratio with 95% confidence intervals (0.66, 0.51 to 0.85) and a table listing the number of subjects at risk for each group at various time points from 0 to 108 months.*

FDA Label Image

Chemical Structure (Structure)

Chemical structure of Bortezomib, showing the molecular arrangement of atoms in the active pharmaceutical ingredient used in the injection, lyophilized powder form by NorthStar RxLLC.*

FDA Label Image

Viallabel (Viallabel)

Label for Bortezomib for Injection 3.5 mg/vial, a lyophilized powder for intravenous or subcutaneous use. It is a single-dose vial labeled as a cytotoxic agent. The label includes storage instructions, manufacturer details (Dr. Reddy's Laboratories Limited, India), and specifies the labeler as NorthStar Rx LLC, Memphis, TN. Barcode and lot/expiration placeholders are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.